CA
RXDX

CHI Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

CHI Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$100M Buy
2022
Q4 		$102M Sell
2022
Q3 		$94.5M Sell
2022
Q2 		$47.2M Buy
2022
Q1 		$59.9M Sell
2021
Q4 		$69.3M Sell
2021
Q3 		$67.9M Buy
2021
Q2 		$70M Sell
2021
Q1 		$52.5M Buy